As mentioned above, Boyle et al. generated a bigenic mouse model of breast cancer combined with CCR7 deletion and revealed that CCR7 ablation results in a considerable delay in tumor onset as well as a significantly reduced tumor burden [23]. This evidence concerns the gene CCR7 and neoplasm.